Revolution Medicines (RVMD) Ending Cash Balance (2019 - 2026)
Revolution Medicines' Ending Cash Balance came in at $820.29 million for Q2 2026, up 101.9% from $406.35 million a year earlier and up 84.0% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Ending Cash Balance (2019 - 2026) Analysis & Trends
For FY2025, Revolution Medicines' Ending Cash Balance was $388.6 million, down 28.9% from FY2024.
- Ending Cash Balance carries a five-year compound annual growth rate of 29.8% (FY2020 to FY2025).
- Going back by year, Ending Cash Balance was $546.76 million in FY2024 (-21.8%), $699.18 million in FY2023 (+328.6%), $163.15 million in FY2022 (+48.0%) and $110.23 million in FY2021 (+4.6%).
- The Q2 2026 figure represents the highest quarterly Ending Cash Balance in data going back to Q1 2019.
- Year-over-year, Ending Cash Balance increased in five of the last eight quarters, with growth averaging 13.8%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q1 2023 (growth of 331.5%), and the weakest in Q1 2022 (a decline of 71.8%).
- Business Quant data shows RVMD's Ending Cash Balance at $445.8 million (Q1 2026), $388.6 million (Q4 2025) and $222.3 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Revolution Medicines | 41.45 Bn | 29.93 Bn | 197.23 Mn | 631.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 631.74 Mn |
| Jun 30, 2026 | 820.29 Mn |
| Mar 31, 2026 | 445.80 Mn |
| Dec 31, 2025 | 388.60 Mn |
| Sep 30, 2025 | 222.30 Mn |
| Jun 30, 2025 | 406.35 Mn |
| Mar 31, 2025 | 337.25 Mn |
| Dec 31, 2024 | 546.76 Mn |
| Sep 30, 2024 | 204.15 Mn |
| Jun 30, 2024 | 278.74 Mn |
| Mar 31, 2024 | 291.46 Mn |
| Dec 31, 2023 | 699.18 Mn |
| Sep 30, 2023 | 360.79 Mn |
| Jun 30, 2023 | 382.92 Mn |
| Mar 31, 2023 | 428.96 Mn |
| Dec 31, 2022 | 163.15 Mn |
| Sep 30, 2022 | 180.68 Mn |
| Jun 30, 2022 | 107.52 Mn |
| Mar 31, 2022 | 99.40 Mn |
| Dec 31, 2021 | 110.23 Mn |
API Access
Revolution Medicines Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();